Life Sciences majors expand digital cancer... Thermo Fisher Scientific has extended its Next Generation Sequencing Companion Dx Center of Excellence Programme (COEP) in Europe. The next-generation sequencing (NGS) provider added a second agreement … more ➔
Nova challenges EUs tank or table pa... A comprehensive sustainability assessment carried out by nova-Institute shows that first and second generation bioethanol is feasible for the EU’s climate strategy. The study challenges the politically … more ➔
Immunooncology: Roche presents blood bioma...Roche is trying to offer a solution for patient selection in immunooncology. At the ESMO congress in Madrid, the theranostics company presented a liquid biopsy test that measures the tumour mutational … more ➔
‘Adrenaline’ of the immune sys... Portuguese and Swiss scientists have discovered that neurons located at mucosal tissues can immediately detect an infection in the organism, promptly producing a substance that acts as an "adrenaline … more ➔
AMAL Therapeutics raises €8mSwiss cancer vaccine developer AMAL Therapeutics has raised €8m in a Series B round led by existing investor Boehringer Ingelheim Venture Fund, and new investors BioMedPartners and Helsinn Investment … more ➔
EU states fuel antimicrobial R&D with... Six European states, together with the Wellcome Trust, and South Africa have pledged €56.5m to help develop new antibiotics that break resistance. more ➔
Smartwatch for patient monitoringResearchers at the University of Sussex have invented a new algorithm that could revolutionise patient monitoring and activity tracking. more ➔
EFSA okays GM bacteria as feed supplementFrench Ajinomoto Eurolysine SAS, part of the world leading producer of amino acids by fermentation, has received a positive safety assessment from the European Food Safety Authority (EFSA) for use of … more ➔
CAR-T: Novartis prices CTL019 at US$475,00...Swiss Novartis AG has received US market authorisation for its first-in-class CAR-T cell therapy Kymriah (tisagenlecleucel-T). As severe cytokine storms seemed to be generally linked to CAR-T therapies … more ➔
FDA approves Boehringers biosimilar adal... The US Food and Drug Administration has granted US market authorisation to Boehringer Ingelheims biosimilar anti-TNFa-antibody adalimumab. more ➔
